Stay updated with breaking news from Adrienne Farid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) insider Adrienne Farid sold 22,831 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $5.14, for a total value of $117,351.34. Following the transaction, the insider now owns 114,149 shares in the company, […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) insider Adrienne Farid sold 22,831 shares of Century Therapeutics stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $5.14, for a total transaction of $117,351.34. Following the sale, the insider now owns 114,149 shares of the company’s stock, valued […]